# Renoprotective Effect of Nisoldipine and Lisinopril in Type 1 Diabetic Nephropathy

> **NCT00311870** · PHASE4 · COMPLETED · sponsor: **Steno Diabetes Center Copenhagen** · enrollment: 52 (—)

## Conditions studied

- Diabetic Nephropathy

## Interventions

- **DRUG:** nisoldipine
- **DRUG:** lisinopril

## Key facts

- **NCT ID:** NCT00311870
- **Lead sponsor:** Steno Diabetes Center Copenhagen
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1993-03
- **Primary completion:** —
- **Final completion:** 1999-04
- **Target enrollment:** 52 (—)
- **Last updated:** 2006-04-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00311870

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00311870, "Renoprotective Effect of Nisoldipine and Lisinopril in Type 1 Diabetic Nephropathy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00311870. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*